Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Non-invasive metabolic imaging of brain tumours in the era of precision medicine.

Nature reviews. Clinical oncology - 1 Dec 2016

Kim Michelle M, Parolia Abhijit, Dunphy Mark P, Venneti Sriram

Abstract excerpt

The revolution in cancer genomics has uncovered a variety of clinically relevant mutations in primary brain tumours, creating an urgent need to develop non-invasive imaging biomarkers to assess and integrate this genetic information into the clinical management of patients. Metabolic reprogramming is a central hallmark of cancer, including brain tumours; indeed, many of the molecular pathways implicated in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Oncogenes
Share to Cell Hypoxia
Share to Citric Acid Cycle

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glioma

Share to Magnetic Resonance Spectroscopy

Share to Neovascularization, Pathologic

Share to Neuroimaging

Share to Positron-Emission Tomography

Source

Open in PubMed Open full text

Identifiers

PMID: 27430748
DOI: 10.1038/nrclinonc.2016.108
PMCID: PMC5115958

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Non-invasive metabolic imaging of brain tumours in the era of precision medicine.PMID 27430748Read ↗

Metabolic reprogramming in the pathogenesis of glioma: UpdateSemantic proximity Read ↗

Imaging Findings of New Entities and Patterns in Brain Tumor: Isocitrate Dehydrogenase Mutant, Isocitrate Dehydrogenase Wild-Type, Codeletion, and MGMT Methylation.Semantic proximity Read ↗

Molecular Imaging of Metabolic Reprograming in Mutant IDH CellsSemantic proximity Read ↗

Update on neuroimaging in brain tumours.Semantic proximity Read ↗

Molecular PET imaging: Unlocking the secrets of cancer metabolismSemantic proximity Read ↗

Altered cellular metabolism in gliomas - an emerging landscape of actionable co-dependency targets.Semantic proximity Read ↗

Metabolic and epigenetic reprogramming in the pathogenesis of glioblastoma: Toward the establishment of “metabolism‐based pathology”Semantic proximity Read ↗

Imaging biomarkers for detecting IDH mutations and monitoring response to novel targeted therapies: Current insights and future perspectives.Semantic proximity Read ↗

Metabolic Imaging and Molecular Signatures Reveal Metabolic Phenotypes in Recurrent Glioblastoma.Semantic proximity Read ↗

The role of amino-acid PET in the light of the new WHO classification 2016 for brain tumors.Semantic proximity Read ↗

Advanced imaging of IDH-mutant gliomas: Precision in diagnosis and management.Semantic proximity Read ↗

Metabolomics of Glioma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.